CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

obicetrapib 10 mg + obicetrapib/evolocumab 140 mg Q 2 weeks - Phase 2 | NAMS Pipeline | CatalystAlert